Matthias Nettekoven - Concepedia

Author

Matthias Nettekoven

Also Known As

M Nettekoven, M. NETTEKOVEN, M. Nettekoven, Matthias H. Nettekoven, Matthias Nettekoven, Nettekoven, M., Nettekoven, Matthias, Peter Mohr

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)University of L'Aquila Dalhousie University European Brain Research Institute Technical University of Munich

About

Matthias Nettekoven is an author at Roche (Switzerland) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	399
2	Natural Sciences	11	12	324
3	Engineering	4	4	104
4	Social Sciences	1	1	34
5	Allergy	1	1	15

Matthias Nettekoven

Publications

911

Citations

H-Index

Page 1

	Year	Citations
Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX<sub>2</sub> receptor P. Malherbe, Edilio Borroni, Luca Gobbi, British Journal of Pharmacology	2009	92
Ligand-Based Combinatorial Design of Selective Purinergic Receptor (A<sub>2A</sub>) Antagonists Using Self-Organizing Maps Gisbert Schneider, Matthias Nettekoven Journal of Combinatorial Chemistry	2003	69
Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process Alexander Alanine, Matthias Nettekoven, Edward Roberts, Combinatorial Chemistry & High Throughput Screening Lead ConversionPharmaceutical ResearchHit IdentificationGreen ChemistryLead Identification	2003	57
Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases Matthias Nettekoven, Jean‐Michel Adam, Stefanie Bendels, ChemMedChem Renal InflammationPharmacotherapyCannabinoid PharmacologyPharmaceutical ChemistryInflammation	2015	56
Benzodioxoles: Novel Cannabinoid-1 Receptor Inverse Agonists for the Treatment of Obesity Leo Alig, Jochem Alsenz, Mirjana Andjelković, Journal of Medicinal Chemistry	2008	42
Evaluation of a flow-photochemistry platform for the synthesis of compact modules Matthias Nettekoven, Bernd Püllmann, Rainer E. Martin, Tetrahedron Letters Chemical EngineeringFlow ChemistryEngineeringPhotoredox ProcessPhotochemistry	2012	40
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design Wolfgang Guba, Werner Neidhart, Matthias Nettekoven Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryVirtual ScreeningDrug TargetBiochemistryFunctional Selectivity	2005	38
Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe Thais Gazzi, Benjamin Brennecke, Kenneth Atz, Chemical Science	2022	35
Synthesis of Fluorinated Tricyclic Scaffolds by Intramolecular [2+2] Photocycloaddition Reactions Diego A. Fort, Thomas J. Woltering, Matthias Nettekoven, Angewandte Chemie International Edition	2012	34
6-Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds Stephan Röver, Mirjana Andjelković, Agnès Bénardeau, Journal of Medicinal Chemistry PharmacotherapyNew SeriesCannabinoid PharmacologySocial SciencesMedicinal Chemistry	2013	34

Page 1